Literature DB >> 3440227

The development of Lhermitte's sign during cisplatin chemotherapy. Possible drug-induced toxicity causing spinal cord demyelination.

P J Walther1, E Rossitch, D E Bullard.   

Abstract

Cisplatin is a recognized neurotoxic agent that commonly causes ototoxicity and peripheral neuropathy. In conjunction with characteristic peripheral neuropathy, two patients treated with high-dose cisplatin developed Lhermitte's sign, a manifestation of posterior column spinal cord pathology. After cisplatin therapy was stopped, this symptom gradually resolved. This suggests that at high doses cisplatin may also cause demyelinating central nervous system lesions involving the spinal cord.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3440227     DOI: 10.1002/1097-0142(19871101)60:9<2170::aid-cncr2820600909>3.0.co;2-n

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Long-term nervous system damage from radiation of the spinal cord: an electrophysiological study.

Authors:  G de Scisciolo; M Bartelli; S Magrini; G P Biti; L Guidi; F Pinto
Journal:  J Neurol       Date:  1991-02       Impact factor: 4.849

Review 2.  The double-edged sword: Neurotoxicity of chemotherapy.

Authors:  Rajiv S Magge; Lisa M DeAngelis
Journal:  Blood Rev       Date:  2014-09-28       Impact factor: 8.250

3.  Cisplatin induced neuropathy: central, peripheral and autonomic nerve involvement.

Authors:  W Boogerd; W W ten Bokkel Huinink; O Dalesio; W J Hoppenbrouwers; J J van der Sande
Journal:  J Neurooncol       Date:  1990-12       Impact factor: 4.130

4.  Lhermitte's sign as a presenting symptom of primary spinal cord tumor.

Authors:  H B Newton; G L Rea
Journal:  J Neurooncol       Date:  1996-08       Impact factor: 4.130

5.  Electric shock-like sensations in 42 cancer patients: clinical characteristics and distinct etiologies.

Authors:  A Lossos; T Siegal
Journal:  J Neurooncol       Date:  1996-08       Impact factor: 4.130

Review 6.  A review on radiogenic Lhermitte's sign.

Authors:  Olga Esik; Tibor Csere; Klára Stefanits; Zsolt Lengyel; Géza Sáfrány; Katalin Vönöczky; Erzsébet Lengyel; Csaba Nemeskéri; Imre Repa; Lajos Trón
Journal:  Pathol Oncol Res       Date:  2003-07-14       Impact factor: 3.201

7.  Lhermitte's Sign Developing after IMRT for Head and Neck Cancer.

Authors:  Dong C Lim; Patrick J Gagnon; Sophia Meranvil; Darryl Kaurin; Linda Lipp; John M Holland
Journal:  Int J Otolaryngol       Date:  2010-06-14

Review 8.  Brain physiome: A concept bridging in vitro 3D brain models and in silico models for predicting drug toxicity in the brain.

Authors:  Yoojin Seo; Seokyoung Bang; Jeongtae Son; Dongsup Kim; Yong Jeong; Pilnam Kim; Jihun Yang; Joon-Ho Eom; Nakwon Choi; Hong Nam Kim
Journal:  Bioact Mater       Date:  2021-11-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.